IR@PKUHSC  > 北京大学临床肿瘤学院  > 病理科
学科主题临床医学
Combined Phenotype of 4 Markers Improves Prognostic Value of Patients With Colon Cancer
Liu, Caiyun1,2; Qu, Like1,2; Dong, Bin3; Xing, Xiaofang1,2; Ren, Tingting1,2; Zeng, Yan1,2; Jiang, Beihai1,2; Meng, Lin1,2; Wu, Jian1,2; Shou, Chengchao1,2
关键词Colon Cancer Lymph Node Metastasis Immunochemistry Combined Analysis
刊名AMERICAN JOURNAL OF THE MEDICAL SCIENCES
2012-04-01
DOI10.1097/MAJ.0b013e31822cb4cd
343期:4页:295-302
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]SYNUCLEIN-GAMMA-GENE ; HUMAN GASTRIC-CANCER ; SOFT-TISSUE SARCOMA ; COLORECTAL-CANCER ; BREAST-CANCER ; MONOCLONAL-ANTIBODIES ; PRL-3 PHOSPHATASE ; LIVER METASTASIS ; STEM-CELLS ; HIWI GENE
英文摘要

Introduction: Combination of multiple biomarkers representing distinct aspects of tumor biology will have a better prognostic value. This study was to identify prognostic subgroups of colon adenocarcinoma by combined analysis of synuclein-gamma (SNCG), a human homologue of piwi (Hiwi), phosphatase of regenerating liver-3 (PRL-3), arrest-defective protein 1, homolog A (ARD1) and clinicopathologic features in 225 colon adenocarcinoma specimens. Methods: Immunohistochemistry for 4 tumor markers was performed in whole tissue sections from 225 colon adenocarcinoma patients with complete clinicopathologic data and up to 10-year follow-up. The immunohistochemical expression patterns were examined individually and in multimarker combinations. Univariate and multivariate analyses were performed to identify independent predictive markers of poor outcome. Results: With the tumor marker positive rate [32.0% (62/225) for SNCG; 76.9% (173/225) for combined SNCG/Hiwi/PRL-3/ARD1] and the detecting accuracy [61.9% (252/407) for SNCG; 82.6% (336/407) for combined SNCG/Hiwi/PRL-3/ARD1] increasing, incremental value of combined SNCG/Hiwi/PRL-3/ARD1 (P < 0.001; hazard ratios (HR), 3.2) to poor outcome was found. Stratified by lymph node, Hiwi alone (P = 0.004; HR, 3.2) led to poor outcome in patients without lymph node metastasis (LN-), and SNCG (P < 0.001; HR, 2.5) had independently poor prognostic value for patients with lymph node metastasis (LN+). Conclusions: Multimarker phenotypes improved tumor positive rate, detecting accuracy and prognostic value. In addition, a subgroup of more aggressive tumors can be identified by evaluating Hiwi level in LN- cancer, and SNCG level in LN+ cancer.

语种英语
WOS记录号WOS:000302158400007
项目编号2009CB521805 ; 2006AA02A249 ; 30671024 ; 30600287 ; 30772489 ; 30973407 ; 2009-3162
资助机构National 973 Program ; National 863 Program ; National Natural Science Foundation of China ; Capital Medical Development Foundation of Beijing
引用统计
被引频次:22[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/53706
专题北京大学临床肿瘤学院_病理科
北京大学第三临床医学院_检验科
北京大学临床肿瘤学院_生化与分子生物学研究室
北京大学临床肿瘤学院_中心实验室
北京大学临床肿瘤学院_标本库
作者单位1.Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China
2.Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China
3.Peking Univ, Canc Hosp & Inst, Dept Pathol, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Liu, Caiyun,Qu, Like,Dong, Bin,et al. Combined Phenotype of 4 Markers Improves Prognostic Value of Patients With Colon Cancer[J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES,2012,343(4):295-302.
APA Liu, Caiyun.,Qu, Like.,Dong, Bin.,Xing, Xiaofang.,Ren, Tingting.,...&Shou, Chengchao.(2012).Combined Phenotype of 4 Markers Improves Prognostic Value of Patients With Colon Cancer.AMERICAN JOURNAL OF THE MEDICAL SCIENCES,343(4),295-302.
MLA Liu, Caiyun,et al."Combined Phenotype of 4 Markers Improves Prognostic Value of Patients With Colon Cancer".AMERICAN JOURNAL OF THE MEDICAL SCIENCES 343.4(2012):295-302.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Caiyun]的文章
[Qu, Like]的文章
[Dong, Bin]的文章
百度学术
百度学术中相似的文章
[Liu, Caiyun]的文章
[Qu, Like]的文章
[Dong, Bin]的文章
必应学术
必应学术中相似的文章
[Liu, Caiyun]的文章
[Qu, Like]的文章
[Dong, Bin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。